Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph early_phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_1
1
25%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
N/A2 (50.0%)

Trials by Status

completed250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingearly_phase_1

Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1

NCT07030725
completednot_applicable

Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI

NCT02139436
unknownnot_applicable

Short Term Intermittent Fasting and Insulin Resistance

NCT02420054
completedphase_1

Computer-based Brief Intervention for Perinatal Substance Abuse

NCT00685074

Clinical Trials (4)

Showing 4 of 4 trials
NCT07030725Early Phase 1

Menthol Stimulation of Brown Adipose Tissue in Humans: Aim 1

Recruiting
NCT02139436Not Applicable

Hybrid-FES Exercise to Prevent Cardiovascular Declines in Acute SCI

Completed
NCT02420054Not Applicable

Short Term Intermittent Fasting and Insulin Resistance

Unknown
NCT00685074Phase 1

Computer-based Brief Intervention for Perinatal Substance Abuse

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4